肿瘤相关中性粒细胞在乳腺癌发生、发展中的作用研究进展

徐睿; 王泽浩; 吴炅

doi:10.19401/j.cnki.1007-3639.2024.09.008

您当前的位置：

首页 >

文章列表页 >

肿瘤相关中性粒细胞在乳腺癌发生、发展中的作用研究进展

综述 | 更新时间：2025-12-31

- 肿瘤相关中性粒细胞在乳腺癌发生、发展中的作用研究进展
- Advances in the role of tumor-associated neutrophils in the development of breast cancer
- 中国癌症杂志 2024年34卷第9期页码：881-889
- 作者机构：
  
  复旦大学附属肿瘤医院乳腺外科，复旦大学上海医学院肿瘤学系，上海 200032
- 作者简介：
  
  [ "徐睿（ORCID: 0009-0005-1908-0981），博士。" ]
  吴炅（ORCID: 0000-0002-8103-0505），博士，主任医师，复旦大学附属肿瘤医院常务副院长。
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2024.09.008
  中图分类号： R737.9
- 收稿：2024-05-20，
  
  修回：2024-09-12，
  
  纸质出版：2024-09-30
- 稿件说明：
移动端阅览
徐睿, 王泽浩, 吴炅. 肿瘤相关中性粒细胞在乳腺癌发生、发展中的作用研究进展[J]. 中国癌症杂志, 2024,34(9):881-889.

Rui XU, Zehao WANG, Jiong WU. Advances in the role of tumor-associated neutrophils in the development of breast cancer[J]. China Oncology, 2024, 34(9): 881-889.
徐睿, 王泽浩, 吴炅. 肿瘤相关中性粒细胞在乳腺癌发生、发展中的作用研究进展[J]. 中国癌症杂志, 2024,34(9):881-889. DOI： 10.19401/j.cnki.1007-3639.2024.09.008.

Rui XU, Zehao WANG, Jiong WU. Advances in the role of tumor-associated neutrophils in the development of breast cancer[J]. China Oncology, 2024, 34(9): 881-889. DOI： 10.19401/j.cnki.1007-3639.2024.09.008.

摘要

中性粒细胞起源于骨髓，由骨髓干细胞增殖分化形成，是血液循环中最常见的多形核白细胞，约占成人外周血白细胞总数的70%。中性粒细胞也是人体内寿命较短的细胞之一，正常成人外周血中性粒细胞半衰期仅数小时，依赖骨髓的不断补充维持中性粒细胞的数量稳定。作为固有免疫系统的短效效应细胞，中性粒细胞参与多种炎症和免疫过程，并构建抵抗感染的第一道防线，在激活和调节先天性及适应性免疫反应中发挥着至关重要的作用。虽然过去人们普遍认为中性粒细胞主要与急、慢性炎症和抗感染过程相关，而由于其寿命较短和不可增殖的特性，一度忽视了其在癌症中的作用。如今越来越多的研究表明，中性粒细胞在癌症中的作用远超以往的认知。乳腺癌是女性常见的恶性肿瘤之一，其发病率和死亡率均位居女性恶性肿瘤的前列。全球范围内乳腺癌的发病率逐年升高，严重威胁全世界女性的身心健康。最近有研究证实，肿瘤相关中性粒细胞（tumor-associated neutrophils，TANs）已成为肿瘤微环境（tumor microenvironment，TME）的重要组成部分，在乳腺癌的发生、发展和转移过程中均发挥重要作用。TANs是由多种肿瘤源性细胞因子相互作用，刺激诱导中性粒细胞募集至TME中积累形成的。中性粒细胞的强可塑性和多样性赋予TANs促进和抑制肿瘤的双重潜能。TANs可通过促进肿瘤生长和转移、推动肿瘤新生血管生成、免疫抑制和生成中性粒细胞胞外诱捕网（neutrophil extracellular traps，NET）来促进乳腺癌进展。反之，TANs也可通过直接杀伤肿瘤细胞和参与形成抗肿瘤的免疫网络间接介导抗肿瘤反应。TANs相关的乳腺癌治疗已逐步成为研究热点，尤其是在三阴性乳腺癌（triple-negative breast cancer，TNBC）中。本综述回顾乳腺癌中TANs起源、形成、分型和功能机制方面的研究进展，并详细阐述TANs与乳腺癌的临床相关性，进一步结合近期乳腺癌中TANs的相关临床研究，系统总结针对乳腺癌患者靶向TANs的治疗策略，以期为乳腺癌中TANs作用机制研究和乳腺癌治疗提供新思路。

Abstract

Neutrophils originate from the bone marrow

differentiating from hematopoietic stem cells

and are the most prevalent polymorphonuclear leukocytes in the blood

accounting for approximately 70% of the total white blood cells in adult peripheral blood. Neutrophils are recognized as one of the relatively short-lived cells in the body

with a normal half-life of just a few hours in the peripheral blood

which rely on continuous replenishment from the bone marrow to maintain the number. As short-lived effectors of the innate immune system

neutrophils participate in various inflammatory and immune processes

and constitute the first line of defense against infection

playing a crucial role in the activation and regulation of both innate and adaptive immunity. Neutrophils were once considered as key effectors of inflammation and infection. Because of their short lifespan and non-proliferative nature

the role of neutrophils in cancer was overlooked. Their role in cancer has been increasingly recognized in recent years. However

more and more studies demonstrate that neutrophils play a much more significant role in cancer than previously thought. Breast cancer is one of the common malignant tumors in women

and its morbidity and mortality are in the forefront of female malignant tumors. The incidence of breast cancer is rising globally

posing a severe threat to the physical and mental health of women worldwide. Recent studies confirm that tumor-associated neutrophils (TANs) have become a critical component of the tumor microenvironment (TME) and play a significant role in the development

progression and metastasis of breast cancer. TANs are formed via the interaction of various tumor-derived cytokines which stimulate and recruit neutrophils to accumulate in the TME. The strong plasticity and diversity of neutrophils endow TANs with dual potential to both promote and inhibit tumors. TANs advance breast cancer progression by promoting tumor growth and metastasis

supporting tumor angiogenesis

immune suppression

and generating neutrophil extracellular traps (NETs). Conversely

TANs mediate antitumor responses through direct tumor cell killing and contributing to the formation of antitumor immune network. Research on TANs-related breast cancer therapies

particularly in triple-negative breast cancer (TNBC)

has become a research hotspot. This review summarized recent advances in the origin

formation

classification and function of TANs in breast cancer

as well as a detailed discussion of their clinical relevance. We further combined recent clinical studies to systematically summarize the treatment strategies targeting TANs in breast cancer

with the aim of providing new insights into the functional mechanisms of TANs and the treatment of breast cancer.

关键词

Keywords

references

NÉMETH T , SPERANDIO M , MÓCSAI A . Neutrophils as emerging therapeutic targets [J ] . Nat Rev Drug Discov , 2020 , 19 ( 4 ): 253 - 275 .

JAILLON S , PONZETTA A , MITRI D D , et al . Neutrophil diversity and plasticity in tumour progression and therapy [J ] . Nat Rev Cancer , 2020 , 20 ( 9 ): 485 - 503 . DOI: 10.1038/s41568-020-0281-y http://doi.org/10.1038/s41568-020-0281-y

CHEN S , ZHANG Q Y , LU L S , et al . Heterogeneity of neutrophils in cancer: one size does not fit all [J ] . Cancer Biol Med , 2022 , 19 ( 12 ): 1629 - 1648 .

BARRY S T , GABRILOVICH D I , SANSOM O J , et al . Therapeutic targeting of tumour myeloid cells [J ] . Nat Rev Cancer , 2023 , 23 ( 4 ): 216 - 237 . DOI: 10.1038/s41568-022-00546-2 http://doi.org/10.1038/s41568-022-00546-2

SUNG H , FERLAY J , SIEGEL R L , et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 .

SOTO-PEREZ-DE-CELIS E , CHAVARRI-GUERRA Y , LEON-RODRIGUEZ E , et al . Tumor-associated neutrophils in breast cancer subtypes [J ] . Asian Pac J Cancer Prev , 2017 , 18 ( 10 ): 2689 - 2693 .

HIDALGO A , CHILVERS E R , SUMMERS C , et al . The neutrophil life cycle [J ] . Trends Immunol , 2019 , 40 ( 7 ): 584 - 597 . DOI: S1471-4906(19)30102-4 http://doi.org/S1471-4906(19)30102-4

FURZE R C , RANKIN S M . Neutrophil mobilization and clearance in the bone marrow [J ] . Immunology , 2008 , 125 ( 3 ): 281 - 288 . DOI: 10.1111/j.1365-2567.2008.02950.x http://doi.org/10.1111/j.1365-2567.2008.02950.x

LEY K , HOFFMAN H M , KUBES P , et al . Neutrophils: new insights and open questions [J ] . Sci Immunol , 2018 , 3 ( 30 ): eaat4579 .

ADROVER J M , DEL FRESNO C , CRAINICIUC G , et al . A neutrophil timer coordinates immune defense and vascular protection [J ] . Immunity , 2019 , 51 ( 5 ): 966 - 967 . DOI: S1074-7613(19)30459-5 http://doi.org/S1074-7613(19)30459-5

LOH W , VERMEREN S . Anti-inflammatory neutrophil functions in the resolution of inflammation and tissue repair [J ] . Cells , 2022 , 11 ( 24 ): 4076 .

ALLEN S J , CROWN S E , HANDEL T M . Chemokine: receptor structure, interactions, and antagonism [J ] . Annu Rev Immunol , 2007 , 25 : 787 - 820 .

FOUSEK K , HORN L A , PALENA C . Interleukin-8: a chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression [J ] . Pharmacol Ther , 2021 , 219 : 107692 .

HE K , LIU X , HOFFMAN R D , et al . G-CSF/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors [J ] . FEBS Open Bio , 2022 , 12 ( 7 ): 1268 - 1285 .

XU Y L , YAN J X , TAO Y , et al . Pituitary hormone α-MSH promotes tumor-induced myelopoiesis and immunosuppression [J ] . Science , 2022 , 377 ( 6610 ): 1085 - 1091 . DOI: 10.1126/science.abj2674 http://doi.org/10.1126/science.abj2674

NOURSHARGH S , RENSHAW S A , IMHOF B A . Reverse migration of neutrophils: where, when, how, and why? [J ] . Trends Immunol , 2016 , 37 ( 5 ): 273 - 286 . DOI: S1471-4906(16)00044-2 http://doi.org/S1471-4906(16)00044-2

CORTEZ-RETAMOZO V , ETZRODT M , NEWTON A , et al . Origins of tumor-associated macrophages and neutrophils [J ] . Proc Natl Acad Sci U S A , 2012 , 109 ( 7 ): 2491 - 2496 .

FRIDLENDER Z G , SUN J , KIM S , et al . Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN [J ] . Cancer Cell , 2009 , 16 ( 3 ): 183 - 194 .

YU X Y , LI C H , WANG Z J , et al . Neutrophils in cancer: dual roles through intercellular interactions [J ] . Oncogene , 2024 , 43 ( 16 ): 1163 - 1177 . DOI: 10.1038/s41388-024-03004-5 http://doi.org/10.1038/s41388-024-03004-5

POETA V M , MASSARA M , CAPUCETTI A , et al . Chemokines and chemokine receptors: new targets for cancer immunotherapy [J ] . Front Immunol , 2019 , 10 : 379 . DOI: 10.3389/fimmu.2019.00379 http://doi.org/10.3389/fimmu.2019.00379

OHMS M , MÖLLER S , LASKAY T . An attempt to polarize human neutrophils toward N1 and N2 phenotypes in vitro [J ] . Front Immunol , 2020 , 11 : 532 .

LIU S Y , WU W C , DU Y S , et al . The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications [J ] . Mol Cancer , 2023 , 22 ( 1 ): 148 . DOI: 10.1186/s12943-023-01843-6 http://doi.org/10.1186/s12943-023-01843-6

CASBON A J , REYNAUD D , PARK C , et al . Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils [J ] . Proc Natl Acad Sci U S A , 2015 , 112 ( 6 ): E566-E575 .

QUE H Y , FU Q M , LAN T X , et al . Tumor-associated neutrophils and neutrophil-targeted cancer therapies [J ] . Biochim Biophys Acta Rev Cancer , 2022 , 1877 ( 5 ): 188762 .

LIANG W , LI Q , FERRARA N . Metastatic growth instructed by neutrophil-derived transferrin [J ] . Proc Natl Acad Sci U S A , 2018 , 115 ( 43 ): 11060 - 11065 .

ZHAO Y , LIU Z S , LIU G Q , et al . Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1 [J ] . Cell Metab , 2023 , 35 ( 10 ): 1688 - 1703 .e10. DOI: 10.1016/j.cmet.2023.09.004 http://doi.org/10.1016/j.cmet.2023.09.004

MA T , TANG Y , WANG T L , et al . Chronic pulmonary bacterial infection facilitates breast cancer lung metastasis by recruiting tumor-promoting MHCⅡ hi neutrophils [J ] . Signal Transduct Target Ther , 2023 , 8 ( 1 ): 296 .

LI P S , LU M , SHI J Y , et al . Lung mesenchymal cells elicit lipid storage in neutrophils that fuel breast cancer lung metastasis [J ] . Nat Immunol , 2020 , 21 ( 11 ): 1444 - 1455 .

NG M S F , KWOK I , TAN L , et al . Deterministic reprogramming of neutrophils within tumors [J ] . Science , 2024 , 383 ( 6679 ): eadf6493 .

LI T J , JIANG Y M , HU Y F , et al . Interleukin-17-producing neutrophils link inflammatory stimuli to disease progression by promoting angiogenesis in gastric cancer [J ] . Clin Cancer Res , 2017 , 23 ( 6 ): 1575 - 1585 .

LIU Z L , CHEN H H , ZHENG L L , et al . Angiogenic signaling pathways and anti-angiogenic therapy for cancer [J ] . Signal Transduct Target Ther , 2023 , 8 ( 1 ): 198 .

KWANTWI L B , WANG S J , ZHANG W J , et al . Tumor-associated neutrophils activated by tumor-derived CCL20 (C-C motif chemokine ligand 20) promote T cell immunosuppression via programmed death-ligand 1 (PD-L1) in breast cancer [J ] . Bioengineered , 2021 , 12 ( 1 ): 6996 - 7006 . DOI: 10.1080/21655979.2021.1977102 http://doi.org/10.1080/21655979.2021.1977102

SPIEGEL A , BROOKS M W , HOUSHYAR S , et al . Neutrophils suppress intraluminal NK cell-mediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells [J ] . Cancer Discov , 2016 , 6 ( 6 ): 630 - 649 . DOI: 10.1158/2159-8290.CD-15-1157 http://doi.org/10.1158/2159-8290.CD-15-1157

GONG Z , LI Q , SHI J Y , et al . Immunosuppressive reprogramming of neutrophils by lung mesenchymal cells promotes breast cancer metastasis [J ] . Sci Immunol , 2023 , 8 ( 80 ): eadd5204 .

SHAO B Z , YAO Y , LI J P , et al . The role of neutrophil extracellular traps in cancer [J ] . Front Oncol , 2021 , 11 : 714357 .

MASUCCI M T , MINOPOLI M , DEL VECCHIO S , et al . The emerging role of neutrophil extracellular traps (NETs) in tumor progression and metastasis [J ] . Front Immunol , 2020 , 11 : 1749 . DOI: 10.3389/fimmu.2020.01749 http://doi.org/10.3389/fimmu.2020.01749

ZHANG Y , GUO L P , DAI Q C , et al . A signature for pan-cancer prognosis based on neutrophil extracellular traps [J ] . J Immunother Cancer , 2022 , 10 ( 6 ): e004210 .

HSU B E , TABARIÈS S , JOHNSON R M , et al . Immature low-density neutrophils exhibit metabolic flexibility that facilitates breast cancer liver metastasis [J ] . Cell Rep , 2019 , 27 ( 13 ): 3902 - 3915 .e6. DOI: S2211-1247(19)30730-2 http://doi.org/S2211-1247(19)30730-2

WANG Y G , DING Y X , GUO N Z , et al . MDSCs: key criminals of tumor pre-metastatic niche formation [J ] . Front Immunol , 2019 , 10 : 172 . DOI: 10.3389/fimmu.2019.00172 http://doi.org/10.3389/fimmu.2019.00172

TEIJEIRA Á , GARASA S , GATO M , et al . CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity [J ] . Immunity , 2020 , 52 ( 5 ): 856 - 871 .e8. DOI: S1074-7613(20)30089-3 http://doi.org/S1074-7613(20)30089-3

TAIFOUR T , ATTALLA S S , ZUO D M , et al . The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer [J ] . Immunity , 2023 , 56 ( 12 ): 2755 - 2772 .e8. DOI: 10.1016/j.immuni.2023.11.002 http://doi.org/10.1016/j.immuni.2023.11.002

MOUSSET A , LECORGNE E , BOURGET I , et al . Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation [J ] . Cancer Cell , 2023 , 41 ( 4 ): 757 - 775 .e10. DOI: 10.1016/j.ccell.2023.03.008 http://doi.org/10.1016/j.ccell.2023.03.008

SCHEDEL F , MAYER-HAIN S , PAPPELBAUM K I , et al . Evidence and impact of neutrophil extracellular traps in malignant melanoma [J ] . Pigment Cell Melanoma Res , 2020 , 33 ( 1 ): 63 - 73 .

FURUMAYA C , MARTINEZ-SANZ P , BOUTI P , et al . Plasticity in pro- and anti-tumor activity of neutrophils: Shifting the balance [J ] . Front Immunol , 2020 , 11 : 2100 . DOI: 10.3389/fimmu.2020.02100 http://doi.org/10.3389/fimmu.2020.02100

GERSHKOVITZ M , CASPI Y , FAINSOD-LEVI T , et al . TRPM2 mediates neutrophil killing of disseminated tumor cells [J ] . Cancer Res , 2018 , 78 ( 10 ): 2680 - 2690 . DOI: 10.1158/0008-5472.CAN-17-3614 http://doi.org/10.1158/0008-5472.CAN-17-3614

AGGARWAL V , TULI H S , VAROL A , et al . Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements [J ] . Biomolecules , 2019 , 9 ( 11 ): 735 .

DENG D , SHAH K . TRAIL of hope meeting resistance in cancer [J ] . Trends Cancer , 2020 , 6 ( 12 ): 989 - 1001 . DOI: 10.1016/j.trecan.2020.06.006 http://doi.org/10.1016/j.trecan.2020.06.006

CUI C , CHAKRABORTY K , TANG X A , et al . Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis [J ] . Cell , 2021 , 184 ( 12 ): 3163 - 3177 .e21. DOI: 10.1016/j.cell.2021.04.016 http://doi.org/10.1016/j.cell.2021.04.016

PONZETTA A , CARRIERO R , CARNEVALE S , et al . Neutrophils driving unconventional T cells mediate resistance against murine sarcomas and selected human tumors [J ] . Cell , 2019 , 178 ( 2 ): 346 - 360 .e24. DOI: S0092-8674(19)30618-X http://doi.org/S0092-8674(19)30618-X

WU Y C , MA J Q , YANG X P , et al . Neutrophil profiling illuminates anti-tumor antigen-presenting potency [J ] . Cell , 2024 , 187 ( 6 ): 1422 - 1439 .e24. DOI: 10.1016/j.cell.2024.02.005 http://doi.org/10.1016/j.cell.2024.02.005

KAKUMOTO A , JAMIYAN T , KURODA H , et al . Prognostic impact of tumor-associated neutrophils in breast cancer [J ] . Int J Clin Exp Pathol , 2024 , 17 ( 3 ): 51 - 62 .

PU N , YIN H L , ZHAO G C , et al . Independent effect of postoperative neutrophil-to-lymphocyte ratio on the survival of pancreatic ductal adenocarcinoma with open distal pancreatosplenectomy and its nomogram-based prediction [J ] . J Cancer , 2019 , 10 ( 24 ): 5935 - 5943 . DOI: 10.7150/jca.35856 http://doi.org/10.7150/jca.35856

HUANG Z N , LI Z X , YAO Z C , et al . Clinical prognostic evaluation of immunocytes in different molecular subtypes of breast cancer [J ] . J Cell Physiol , 2019 , 234 ( 11 ): 20584 - 20602 . DOI: 10.1002/jcp.28662 http://doi.org/10.1002/jcp.28662

VON AU A , SHENCORU S , UHLMANN L , et al . Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancer [J ] . Arch Gynecol Obstet , 2023 , 307 ( 4 ): 1105 - 1113 .

ZHANG X , GE X , JIANG T , et al . Research progress on immunotherapy in triple-negative breast cancer (Review) [J ] . Int J Oncol , 2022 , 61 ( 2 ): 95 .

HE J , ZHOU M X , YIN J , et al . METTL3 restrains papillary thyroid cancer progression via m6A/c-Rel/IL-8-mediated neutrophil infiltration [J ] . Mol Ther , 2021 , 29 ( 5 ): 1821 - 1837 .

LIN Q , FANG X L , LIANG G H , et al . Silencing CTNND1 mediates triple-negative breast cancer bone metastasis via upregulating CXCR4/CXCL12 axis and neutrophils infiltration in bone [J ] . Cancers , 2021 , 13 ( 22 ): 5703 .

YANG C H , WANG Z , LI L L , et al . Aged neutrophils form mitochondria-dependent vital NETs to promote breast cancer lung metastasis [J ] . J Immunother Cancer , 2021 , 9 ( 10 ): e002875 .

PENG H M , SHEN J , LONG X , et al . Local release of TGF-β inhibitor modulates tumor-associated neutrophils and enhances pancreatic cancer response to combined irreversible electroporation and immunotherapy [J ] . Adv Sci , 2022 , 9 ( 10 ): e2105240 .

YU R R , ZHU B , CHEN D G . Type I interferon-mediated tumor immunity and its role in immunotherapy [J ] . Cell Mol Life Sci , 2022 , 79 ( 3 ): 191 . DOI: 10.1007/s00018-022-04219-z http://doi.org/10.1007/s00018-022-04219-z

VEGLIA F , TYURIN V A , BLASI M , et al . Fatty acid transport protein 2 reprograms neutrophils in cancer [J ] . Nature , 2019 , 569 ( 7754 ): 73 - 78 .

LINDE I L , PRESTWOOD T R , QIU J T , et al . Neutrophil-activating therapy for the treatment of cancer [J ] . Cancer Cell , 2023 , 41 ( 2 ): 356 - 372 .e10. DOI: 10.1016/j.ccell.2023.01.002 http://doi.org/10.1016/j.ccell.2023.01.002

VAZQUEZ RODRIGUEZ G , ABRAHAMSSON A , JENSEN L D , et al . Estradiol promotes breast cancer cell migration via recruitment and activation of neutrophils [J ] . Cancer Immunol Res , 2017 , 5 ( 3 ): 234 - 247 . DOI: 10.1158/2326-6066.CIR-16-0150 http://doi.org/10.1158/2326-6066.CIR-16-0150

MINOR B M N , LEMOINE D , SEGER C , et al . Estradiol augments tumor-induced neutrophil production to promote tumor cell actions in lymphangioleiomyomatosis models [J ] . Endocrinology , 2023 , 164 ( 6 ): bqad061 .

DAASSI D , MAHONEY K M , FREEMAN G J . The importance of exosomal PD-L1 in tumour immune evasion [J ] . Nat Rev Immunol , 2020 , 20 ( 4 ): 209 - 215 .

WANG T T , ZHAO Y L , PENG L S , et al . Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway [J ] . Gut , 2017 , 66 ( 11 ): 1900 - 1911 .

KHOU S , POPA A , LUCI C , et al . Tumor-associated neutrophils dampen adaptive immunity and promote cutaneous squamous cell carcinoma development [J ] . Cancers , 2020 , 12 ( 7 ): 1860 .

ZHAO Y , BAI Y S , SHEN M L , et al . Therapeutic strategies for gastric cancer targeting immune cells: future directions [J ] . Front Immunol , 2022 , 13 : 992762 .

SUN R , XIONG Y Y , LIU H J , et al . Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis [J ] . Transl Oncol , 2020 , 13 ( 10 ): 100825 .

浏览量

2182

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

中国乳腺癌重要基础转化研究——进展与展望

2022年中国乳腺癌重要临床试验成果及最新进展

在乳腺癌局部精准治疗中的新进展：联合免疫治疗未来可期

2025年中国乳腺癌重要临床试验成果